Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China
· Delayed Price · Currency is CNY 18.63
+0.25 (1.36%)
Mar 10, 2026, 11:45 AM CST
SHE:002932 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 183.86 | 493.91 | 1,016 | 2,556 | 1,190 | 669.11 | Upgrade
|
| Short-Term Investments | 3,162 | 738.79 | - | 70 | - | - | Upgrade
|
| Trading Asset Securities | 404.92 | 64.12 | 122.59 | 1,953 | 700 | 200 | Upgrade
|
| Cash & Short-Term Investments | 3,750 | 1,297 | 1,138 | 4,578 | 1,890 | 869.11 | Upgrade
|
| Cash Growth | 572.47% | 13.93% | -75.14% | 142.22% | 117.48% | 134.57% | Upgrade
|
| Accounts Receivable | 652.72 | 766.95 | 1,254 | 2,736 | 740.42 | 185.03 | Upgrade
|
| Other Receivables | 17.81 | 80.52 | 70.28 | 17.52 | 11.97 | 5.46 | Upgrade
|
| Receivables | 670.53 | 847.47 | 1,324 | 2,754 | 752.39 | 190.49 | Upgrade
|
| Inventory | 101.35 | 82.3 | 128.77 | 258.44 | 284.59 | 117.73 | Upgrade
|
| Other Current Assets | 224.06 | 171.08 | 158.83 | 91.09 | 72.98 | 40.77 | Upgrade
|
| Total Current Assets | 4,746 | 2,398 | 2,750 | 7,682 | 3,000 | 1,218 | Upgrade
|
| Property, Plant & Equipment | 676.65 | 721.68 | 543.6 | 521.59 | 243.47 | 123.26 | Upgrade
|
| Long-Term Investments | 254.22 | 257.61 | 156.36 | 83.49 | 60.62 | 46.4 | Upgrade
|
| Other Intangible Assets | 16.61 | 17.3 | 17.7 | 21.24 | 16.59 | 16.93 | Upgrade
|
| Long-Term Deferred Tax Assets | 216.26 | 216.9 | 210.18 | 173.95 | 16.63 | 7.6 | Upgrade
|
| Long-Term Deferred Charges | 2.32 | 3.11 | 14.87 | 17.21 | 1.45 | 1.74 | Upgrade
|
| Other Long-Term Assets | 188.68 | 2,979 | 3,694 | 695.33 | 78.24 | 12.61 | Upgrade
|
| Total Assets | 6,101 | 6,593 | 7,387 | 9,195 | 3,417 | 1,427 | Upgrade
|
| Accounts Payable | 144.76 | 278.11 | 681.58 | 1,294 | 174.31 | 30.94 | Upgrade
|
| Accrued Expenses | 52.38 | 87.97 | 154.94 | 364.68 | 83.18 | 29.78 | Upgrade
|
| Short-Term Debt | 3 | 3 | 23.61 | 164.67 | 30 | 141.5 | Upgrade
|
| Current Portion of Leases | 4.3 | 4.3 | 7.29 | 18.17 | 3.62 | - | Upgrade
|
| Current Income Taxes Payable | 5.77 | 6.44 | 6.27 | 144.02 | 131.8 | 24.58 | Upgrade
|
| Current Unearned Revenue | 35.28 | 37.96 | 53.17 | 309.58 | 71.18 | 27.74 | Upgrade
|
| Other Current Liabilities | 52.01 | 78.07 | 92.5 | 69.96 | 51.9 | 54.87 | Upgrade
|
| Total Current Liabilities | 297.5 | 495.86 | 1,019 | 2,365 | 545.98 | 309.42 | Upgrade
|
| Long-Term Leases | 3.45 | 5.82 | 18.25 | 20.75 | 10.74 | - | Upgrade
|
| Long-Term Unearned Revenue | 20.87 | 20.87 | 14.26 | 5.96 | 5.96 | 0.02 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 51.67 | 50.42 | 39.59 | 31.07 | 4.33 | 2.32 | Upgrade
|
| Other Long-Term Liabilities | 0.22 | 1.44 | 3.03 | - | - | - | Upgrade
|
| Total Liabilities | 373.7 | 574.4 | 1,094 | 2,423 | 567.02 | 311.77 | Upgrade
|
| Common Stock | 232.5 | 232.52 | 232.52 | 156.19 | 104.88 | 69.01 | Upgrade
|
| Additional Paid-In Capital | 818.1 | 818.1 | 820.18 | 887.89 | 904.5 | 400.24 | Upgrade
|
| Retained Earnings | 4,758 | 5,014 | 4,973 | 5,472 | 1,812 | 681.94 | Upgrade
|
| Treasury Stock | -247.96 | -237.95 | - | -16.02 | -32.77 | -49.39 | Upgrade
|
| Total Common Equity | 5,561 | 5,826 | 6,026 | 6,500 | 2,789 | 1,102 | Upgrade
|
| Minority Interest | 166.32 | 192.29 | 266.21 | 271.92 | 61.25 | 13.09 | Upgrade
|
| Shareholders' Equity | 5,727 | 6,019 | 6,292 | 6,772 | 2,850 | 1,115 | Upgrade
|
| Total Liabilities & Equity | 6,101 | 6,593 | 7,387 | 9,195 | 3,417 | 1,427 | Upgrade
|
| Total Debt | 10.75 | 13.11 | 49.16 | 203.59 | 44.36 | 141.5 | Upgrade
|
| Net Cash (Debt) | 3,740 | 1,284 | 1,089 | 4,375 | 1,846 | 727.61 | Upgrade
|
| Net Cash Growth | 605.79% | 17.87% | -75.10% | 137.02% | 153.67% | 96.38% | Upgrade
|
| Net Cash Per Share | 17.24 | 5.68 | 4.80 | 19.03 | 8.72 | 3.49 | Upgrade
|
| Filing Date Shares Outstanding | 219.47 | 220.05 | 232.52 | 232.73 | 232.84 | 214.48 | Upgrade
|
| Total Common Shares Outstanding | 219.47 | 220.05 | 232.52 | 232.73 | 232.84 | 214.48 | Upgrade
|
| Working Capital | 4,449 | 1,902 | 1,731 | 5,317 | 2,454 | 908.68 | Upgrade
|
| Book Value Per Share | 25.34 | 26.48 | 25.92 | 27.93 | 11.98 | 5.14 | Upgrade
|
| Tangible Book Value | 5,545 | 5,809 | 6,008 | 6,479 | 2,772 | 1,085 | Upgrade
|
| Tangible Book Value Per Share | 25.26 | 26.40 | 25.84 | 27.84 | 11.91 | 5.06 | Upgrade
|
| Buildings | - | 440.3 | 116.98 | 116.66 | 78 | 51.08 | Upgrade
|
| Machinery | - | 380.8 | 402.91 | 374.05 | 158.18 | 113.44 | Upgrade
|
| Construction In Progress | - | 120.79 | 185.19 | 121.52 | 73.58 | 19.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.